Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ADDvise Group AB (publ) (the "Company" and together with its subsidiaries from time to time, the "Group") has instructed the agent for the Company's up to SEK 500,000,000 senior secured bonds with ISIN SE0015222088 (the "Bonds") to initiate a written procedure to request that bondholders vote in favour of (i) amending and restating items (i) and (r) of the definition "Permitted Debt" in the terms and conditions of the Bonds (the "Terms and Conditions") and (ii) amending and restating item (f) of the definition "Permitted Security" in the Terms and Conditions (the "Proposal").
The proposed amendments will enable the Company to optimise the Group's working capital financing and to limit the amount which must be paid upfront for future acquisitions. This will reduce the Group's overall funding cost as well as the financial risk associated with acquisitions, allow the Company to continue to pursue attractive and sizeable acquisitions, and facilitate the overall continued growth of the Group.
Bondholders together representing approximately 50 per cent of the outstanding volume under the Bonds have expressed their support for the Proposal.
The agent will deliver the notice of a written procedure to all bondholders on 16 December 2021. The written procedure will commence on 22 December 2021 and end on 14 January 2022. To be eligible to participate in the written procedure a holder must fulfil the formal criteria for being a bondholder on 22 December 2021. This means that the holder must be registered on a securities account with Euroclear Sweden AB as a direct registered owner (Sw. direktregistrerad ägare) or authorised nominee (Sw. förvaltare) with respect to one or several Bonds.
Pareto Securities AB has been retained as financial advisor in connection with the written procedure.
The notice of a written procedure is available on the Company's website (addvisegroup.com) and on website of the agent (intertrustgroup.com).
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.